title: [Comparison of conventional and conformational dosimetry in radiotherapy of cerebral neoplasms].
abstract: OBJECTIVE
  We prospectively compared a conventional treatment planning (PT2D) and 3-dimensional conformal treatment planning (PT3D) for radiotherapy of cerebral tumours.
  
  
  METHODS
  Patients treated between 1/10/98 and 1/4/99 by irradiation for cerebral tumours were analysed. For each case, we planned PT2D using conventional orthogonal x-ray films, and afterward, PT3D using CT scan. Gross tumor volume, planning target volume and normal tissue volumes were defined. Dose was prescribed according to report 50 of the International Commission on Radiation Units and Measurements (ICRU). We compared surfaces of sagittal view targets defined on PT2D and PT3D and called them S2D and S3D, respectively. Irradiated volumes by 90% isodoses (VE-90%) and normal tissue volumes irradiated by 20, 50, 90% isodoses were calculated and compared using Student's paired t-test.
  
  
  RESULTS
  There was a concordance of 84% of target surfaces defined on PT2D and PT3D. Percentages of target surface under- or-over defined by PT2D were 16 and 13% respectively. VE-90% was decreased by 15% (p = 0.07) with PT3D. Normal brain volume irradiated by 90% isodose was decreased by 27% with PT3D (p = 0.04).
  
  
  CONCLUSIONS
  For radiotherapy of cerebral tumors using only coplanar beams, PT3D leads to a reduction of normal brain tissue irradiated. We recommend PT3D for radiotherapy of cerebral tumors, particularly for low-grade or benign tumors (meningiomas, neuromas, etc.).
authors.affiliation: Département de radiothérapie, centre Oscar-Lambret, BP 307, 59020 Lille, France. jm-caudrelier@o-lambret.fr
authors.forename: J M
authors.initials: JM
authors.lastname: Caudrelier
authors.forename: A
authors.initials: A
authors.lastname: Auliard
authors.forename: T
authors.initials: T
authors.lastname: Sarrazin
authors.forename: D
authors.initials: D
authors.lastname: Gibon
authors.forename: B
authors.initials: B
authors.lastname: Coche-Dequéant
authors.forename: B
authors.initials: B
authors.lastname: Castelain
mesh_terms: D001932:Brain Neoplasms / Q000532:radiotherapy*; D006801:Humans; D011446:Prospective Studies; D011879:Radiotherapy Dosage; D011881:Radiotherapy, Computer-Assisted; D020266:Radiotherapy, Conformal; D016896:Treatment Outcome